Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 89Recruiting 40Terminated 30Unknown 14Active not recruiting 14Withdrawn 7Not yet recruiting 3Suspended 2Available 2Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 9NET 1Lymphoid 1Endocrine 1Classical hematology 1Breast 1

Conditions

Breast Neoplasms 73Prostatic Neoplasms 5Ovarian Neoplasms 5Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 4Stomach Neoplasms 4Lymphedema 4Lung Neoplasms 3Colorectal Neoplasms 3Anxiety Disorders 3Uterine Cervical Neoplasms 2Neuroendocrine Tumors 2Melanoma 2Lymphoma 2Fatigue 2Depression 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Breast Cancer Metastatic 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Tinnitus 1Thyroid Neoplasms 1Tension-Type Headache 1TNBC 1Stroke 1Stress Disorders, Post-Traumatic 1Squamous Cell Carcinoma of Head and Neck 1Spinal Stenosis 1

Interventions

Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Sarcoma × Breast × Clear all
NCT05396118 2024-05-14

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

Rigshospitalet, Denmark

Phase 2 Enrolling by invitation
15 enrolled
BreastEndocrineLymphoidNETSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡